| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285800 | Parkinsonism & Related Disorders | 2017 | 5 Pages |
Abstract
This is the first report assessing orexin immunoreactivity in Perry syndrome, and it showed significant reduction, similar to select neurodegenerative diseases, such as MSA. Further analysis with more cases will be needed to elucidate the specific mechanism of orexin loss in these disorders.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Takayasu Mishima, Koji Kasanuki, Shunsuke Koga, Monica Castanedes-Casey, Zbigniew K. Wszolek, Yoshio Tsuboi, Dennis W. Dickson,